Abstract:AIM:To investigate the expression of E-cadherin,β-catenin and Cyclin D1 and their relationships and clinical pathological features in gastric adenocarcinoma. METHODS:Immunohistochemical SP method was used to determine the expression of E-cad- herin,β-catenin and Cyclin D1 protein in 73 cases of gastric adenocarcinoma tissues and 18 cases of normal gastric mucosal tissues. RESULTS:Positive staining for E-cadherin andβ-catenin was observed on the cellular membrane of epithelial cells in normal gastric mucosal tissues.The aberrant expression of E-cadherin andβ-catenin were observed in the cytoplasm and/or cellular nucleus of gastric cancer cells.The aberrant expression rates of E-cadherin andβ-catenin were 63.01%(46/73) and 56.16%(41/73)in gastric adenocarcinoma, respectively,which were associated with the differentiation degree,TNM stages,depth of infiltration and lymph node metastasis,but not with the gender,age and tumor size.There was a significant correlation between E-cadherin andβ-catenin expression in gastric adenocarcinoma. The positive rate of Cyclin D1 expression was 67.12%(49/73)in gastric adenocarcinoma,no- tably higher than that in normal gastric tissues (0/18,P＜0.01),and it was correlated with the differentiation degree and lymph node metasta- sis.The aberrant expression of E-cadherin andβ-catenin were positively correlated with the high expression of Cyclin D1 gastric carcinoma(r =0.249,0.376,both P＜0.05). CONCLUSION:Down-regulated expression of E-cadherin andβ-catenin exist in gastric carci- noma,which may promote the pathogenesis and development of carcinoma by activation of Cy- clin D1.

Expression of E-cadherin, β-catenin and Cyclin D1 in gastric adenocarcinoma and their clinical significances